DUBLIN--(http://www.researchandmarkets.com/research/l53r37/anxiety_disorders) has announced the addition of Global Markets Direct's new report "Anxiety Disorders - Pipeline Review, H2 2012" to their offering.)--Research and Markets (
“Anxiety Disorders - Pipeline Review, H2 2012”
This report provides information on the therapeutic development for Anxiety Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anxiety Disorders.
Anxiety Disorders - Pipeline Review, Half Year is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
- A snapshot of the global therapeutic scenario for Anxiety Disorders.
- A review of the Anxiety Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Anxiety Disorders pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Involved in Anxiety Disorders Therapeutics Development
- Johnson & Johnson
- Avineuro Pharmaceuticals, Inc.
- AcelRx Pharmaceuticals, Inc.
- Eisai Co., Ltd.
- Addex Pharmaceuticals
- Neuralstem, Inc.
- Ligand Pharmaceuticals Incorporated
- NovaDel Pharma, Inc.
- Ironwood Pharmaceuticals, Inc.
- Abiogen Pharma S.p.A.
- Global Health Ventures Inc.
- Psylin Neurosciences, Inc.
- Azevan Pharmaceuticals, Inc.
- CeNeRx BioPharma, Inc.
- Concert Pharmaceuticals, Inc.
- Omeros Corporation
- Targacept, Inc.
- Vanda Pharmaceuticals Inc.
- Adamed Sp. z o.o.
- NeuroTherapeutics Pharma Inc.
- Cannasat Therapeutics, Inc.
- Lee's Pharmaceutical Holdings Limited
- Heptares Therapeutics Ltd.
- Pherin Pharmaceuticals, Inc.
- Beech Tree Labs, Inc.
- Naurex, Inc.
For more information visit http://www.researchandmarkets.com/research/l53r37/anxiety_disorders
Source: Global Markets Direct